首页 | 本学科首页   官方微博 | 高级检索  
     


Impact of time to testosterone rebound and comorbidity on the risk of cause‐specific mortality in men with unfavorable‐risk prostate cancer
Authors:Susan G.R. McDuff MD  PhD  Ming‐Hui Chen PhD  Andrew A. Renshaw MD  Marian J. Loffredo RN  Philip W. Kantoff MD  Anthony V. D'Amico MD  PhD
Affiliation:1. Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana‐Farber Cancer Institute, Boston, Massachusetts;2. Department of Radiation Oncology, Brigham and Women's Hospital, Dana‐Farber Cancer Institute, Boston, Massachusetts;3. Department of Statistics, University of Connecticut, Storrs, Connecticut;4. Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida;5. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Abstract:
Keywords:androgen deprivation  comorbidity  prostate cancer  survival  testosterone rebound
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号